Stem cell treatment for non-lacunar stroke after the first day
Part of Brain & nervous system, Heart & circulation clinical trials.
This early-phase study tests a stem cell treatment for certain types of stroke, focusing first on safety and the right dose. It may help doctors learn whether the treatment is safe and potentially beneficial when given soon after stroke begins.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have had an ischemic stroke that affects one side of the brain (not a “lacunar” stroke), confirmed on CT/MRI
- Be admitted to the stroke unit within 24 hours of stroke start, and enroll between 24 and 48 hours after stroke onset
- Have stroke severity at least moderate (NIHSS score 7 or higher, with arm/leg/hand weakness score 3 or higher)
- Be able to take part in a rehabilitation program and follow study visits
- Have no decompressive brain surgery planned or already done and be able to have MRI scans
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a patient's own stem cells can be safely injected into the brain to help recovery after a stroke. It is for people who had an ischemic stroke 6 months to 5 years ago and still have moderate to severe symptoms.
This trial tests whether an investigational study drug can improve outcomes after an acute ischemic stroke (a stroke caused by blocked blood flow). You may be eligible if you are able to start treatment quickly after symptom onset and have a moderate stroke severity on a standard stroke exam.
This trial tests if the clot-busting drug tenecteplase can help people with a moderate to severe stroke when given 24 to 72 hours after symptoms began. It aims to see if this later treatment window can improve recovery and reduce disability.
This clinical trial is testing a treatment made from stem cell exosomes — tiny particles that help cells communicate — given through an IV to people who have had a recent ischemic stroke caused by a blood clot. The study aims to see if it's safe and can help recovery when given within the first few days after a stroke.
This trial is testing a new treatment using stem cells from donated umbilical cord tissue to help people recover from a recent moderate to severe stroke. It is for patients who cannot receive standard clot-busting treatments.
This trial tests whether stem cell-derived extracellular vesicles can help people recover after a moderate to severe stroke. You may join if you had a stroke in the last 5 days and still have arm or leg weakness, even after standard treatments like clot-busting drugs or clot removal.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.